- What makes healthcare tech GTM different from generic B2B GTM?
- Healthcare tech has three structural differences that define the motion. First, buying cycles are the longest in B2B — 12 to 18 months is normal for mid-market health systems, and 18 to 24 months is common for enterprise hospital groups. Second, the buying committee includes clinical stakeholders (CMIO, VP Clinical Ops, physician champions) whose approval logic is entirely different from administrative or IT approval. Clinicians care about patient outcomes, workflow fit, and evidence from peer institutions, not software feature lists. Third, HIPAA, the 21st Century Cures Act, and EHR integration reality mean every deal has a compliance and technical review that cannot be rushed. Treating healthcare tech like generic SaaS is how vendors burn three years of runway chasing deals that never close.
- How do you actually sell to hospitals and health systems without getting stuck?
- By mapping the buying committee before the first meeting and running a multi-year relationship, not a six-month sales cycle. Health systems buy on fiscal-year calendars tied to capital planning, and the purchase you want this year was budgeted last year. That means GTM has to run on two tracks: in-cycle deals where a committed project exists, and long-horizon relationship building for deals that will land in 12 to 24 months. We build account plans that reflect this reality, multi-thread across CMIO, CIO, VP Clinical Ops, physician champions, and procurement from the first quarter, and pair the sales motion with evidence-based content that clinical buyers trust. Our outbound sales agency and fractional VP of sales services are built around this.
- How do you run HIPAA-compliant outbound and demand generation?
- HIPAA governs the handling of Protected Health Information, not prospect data for marketing. Standard outbound and demand generation to healthcare professionals — using publicly available titles, work emails, and firmographic data — does not touch HIPAA at all. Where HIPAA does hit GTM is in content and product-marketing workflows that involve patient data, case studies with patient information, or any integration demo. We help health tech vendors structure case studies with proper de-identification, handle customer evidence without exposing PHI, and set up CRM and marketing automation workflows that keep the compliance posture clean. The bigger compliance concern in health tech GTM is actually the customer's procurement process — every hospital has a vendor risk assessment and BAA (Business Associate Agreement) review, which we help vendors pre-stage.
- How long are healthcare tech sales cycles really, and why?
- Mid-market health systems run 9 to 15 months. Large hospital groups and IDNs run 15 to 24 months, sometimes longer for enterprise-wide clinical software. The length is driven by committee size (often 8 to 15 stakeholders), capital budgeting cycles that lock investment decisions a year ahead, clinical validation steps (pilot studies, physician review boards, workflow assessments), EHR integration planning (Epic, Cerner/Oracle, Meditech, Athena), and security and BAA review. Payer sales are similar — 12 to 18 months is typical. GTM engagements in health tech have to be designed for this reality; anything priced as a 90-day pipeline sprint is selling into the wrong buyer segment.
- How do you multi-thread across clinical, IT, and administrative stakeholders?
- Different content, different messaging, different sequences for each role — run in parallel. Clinical stakeholders (CMIO, CNIO, VP Clinical Ops, department chairs) respond to peer-reviewed evidence, workflow fit, and stories from comparable institutions. IT stakeholders (CIO, CTO, Head of Clinical Systems) respond to integration depth, security, and EHR compatibility. Administrative stakeholders (CFO, COO, VP Revenue Cycle) respond to ROI, operational metrics, and payback windows. We build three parallel tracks of outbound, content, and enablement — one for each audience — and connect them inside a single account plan so the champion can use our materials to win internal consensus. Our SDR agency and demand generation agency services run this way by default for healthcare clients.
- How do you handle EHR integration conversations without over-promising?
- Integration is the single most common reason health tech deals die late. A vendor claims Epic or Cerner integration, a hospital IT team investigates, and the reality turns out to be a read-only API that does not meet clinical workflow needs. We help health tech companies document their integration reality honestly — which EHRs, which modules, which HL7 or FHIR interfaces, which deployment patterns work, which do not — and then use that document to qualify in or out at the top of the funnel. Over-qualified leads that understand the integration reality convert at a higher rate than under-qualified leads that die in IT review six months in. Honesty compounds; exaggeration does not.
- What role does clinical evidence and published research play in health tech GTM?
- An enormous role, and it is underused by most early-stage health tech vendors. Clinical buyers — especially physician champions and CMIOs — make purchase decisions partly on evidence they can defend internally. A peer-reviewed publication, a white paper with a reputable health system, a quantified outcome study, or a conference presentation carries more weight than any product demo. We help health tech vendors structure their customer evidence into citable formats, publish case studies with outcome data (carefully, with patient privacy protected), and build content that physicians can share in clinical review committees. This is the single biggest leverage point we see in health tech content strategy and one of the most defensible assets a health tech company can build.
- Do you work with companies selling into hospitals, payers, or pharma?
- Primarily health tech vendors selling into hospitals, health systems, payers, and value-based care organisations. We have less experience with pharma-facing GTM (the pharma buyer is structurally different — medical affairs, commercial ops, and regulatory all play different roles than in provider GTM), and we do not take on pure consumer health or DTC work. Within provider and payer tech, we work across clinical software, workflow tools, revenue cycle, interoperability, patient engagement, population health, telehealth, and clinical decision support.
- How do you find the right buyer at a hospital when org charts are opaque?
- Hospitals and health systems have some of the least-public organisational structures in B2B. The CMIO who owns your decision may not appear on LinkedIn with a clean title, physician champions rarely have "champion" in their job description, and the VP Clinical Operations at one system sits under the COO while at another it sits under the CMO. We invest in manual account mapping at the top of the funnel — using directory research, conference attendee lists, publication databases, and LinkedIn graph search — rather than relying on generic data providers that miss clinical roles entirely. The upfront cost is higher but the outbound conversion rate is roughly double what vendors get with a generic list pull.
- What does a healthcare tech GTM engagement with UpliftGTM look like?
- Positioning and buyer audit first, because health tech messaging routinely talks to the wrong stakeholder. Then a combination of outbound, SEO, demand generation, and enablement scoped to the stage of your company and the shape of your buyer. Engagements run 9 to 18 months because health tech cycles demand patience — we will not take on an engagement with a three-month horizon because the work cannot pay back on that timeline. Reporting is tied to qualified pipeline, sales-accepted opportunities, and pilot conversions — not MQLs, which are a near-meaningless metric in health tech. You own the entire GTM system, including the trust and compliance enablement assets, when we hand off.